<DOC>
	<DOCNO>NCT02058628</DOCNO>
	<brief_summary>This randomize , comparator-controlled , single-blind , parallel-group study . The current study proposes compare fixed-dose combination product contain 3 % benzoyl peroxide ( BPO ) 1 % clindamycin cream contain 20 % azelaic acid treatment facial acne vulgaris . The result study enable well assessment safety efficacy new dose regime ( BPO 3 % + clindamycin 1 % ) comparison well establish treatment . Based data evidence base recommendation possible improve treatment subject acne vulgaris . A total 220 subject enrol 5 study visit ( Day 1 , Weeks 2 , 4 , 8 12 ) . The duration study 12 week .</brief_summary>
	<brief_title>Comparison Efficacy Safety Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation Treatment Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Subjects male females 12 45 year age , inclusive . Subjects acne vulgaris : minimum 17 maximum 60 inflammatory facial lesion ( papule pustule ) , include nose , 1 facial nodular cystic lesion minimum 20 maximum 125 noninflammatory facial lesion ( open close comedo ) ISGA score 2 3 . Subjects agree use sunbeds undergo ultraviolet ( UV ) light treatment 4 week prior enter study minimize amount exposure direct sunlight duration study . Subjects capable understanding willing provide sign dated write voluntary informed consent protocolspecific procedure perform . Subjects legal age consent must provide assent write , informed consent parent legal guardian . Unable comply requirement study . Female subject pregnant , breastfeeding , sexually active use reliable contraception and/or prepared duration trial ( negative pregnancy test must confirm Visit 1 , 3 , 4 5 , female menarche occur ) . Subjects clinically relevant find baseline physical examination medical history severe systemic disease diseases facial skin acne vulgaris . Subjects facial hair may obscure accurate assessment acne grade . Subjects history presence regional enteritis inflammatory bowel disease ( eg , ulcerative colitis , pseudomembranous colitis , chronic diarrhea , history antibioticassociated colitis ) similar symptom . Prior Therapy : Have receive treatment follow therapy time specify prior Baseline : systemic retinoids [ 6 month ] ; systemic antibiotic , investigational therapy , facial procedure ( chemical laser peel , microdermabrasion , artificial UV therapy ) , topical corticosteroid face systemic corticosteroid [ 4 week ] ; topical antibiotic face , topical antiacne medication ( eg , BPO , retinoids , azelaic acid , resorcinol , salicylate , sulfacetamide sodium derivative , glycolic acid ) [ 2 week ] ; medication report exacerbate acne ( eg , megadoses certain vitamin vitamin D , vitamin A , vitamins B2 , B6 , B12 ; haloperidol ; halogen iodide bromide ; lithium ; hydantoin ; phenobarbital ) may impact efficacy assessment , neuromuscular block agent ( Clindamycin neuromuscular block activity , may enhance action neuromuscular block agent ) , drug know photosensitizers ( eg , thiazide , tetracycline , fluoroquinolones , phenothiazine , sulfonamide ) possibility increase phototoxicity [ 1 day ] . Subjects unwilling stop use follow type facial product study : astringent , toner , abradant , facial , peel contain glycolic acid , mask , wash soap contain BPO , sulfacetamide sodium salicylic acid , nonmild facial cleanser , moisturizers contain retinol , salicylic acid , alpha betahydroxy acid . Subjects know hypersensitivity previous allergic reaction active component ( azaleic acid , lincomycin , clindamycin , BPO ) , excipients study medication . Use estrogens , include oral , implanted , topical contraceptive , androgen , antiandrogenic agent le 12 consecutive week prior start study dosing ( change dose drug permit 12 week prior study dose end study ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>azelaic acid</keyword>
	<keyword>Clindamycin</keyword>
	<keyword>Benzoyl peroxide</keyword>
	<keyword>Acne vulgaris</keyword>
</DOC>